CE
Celanese CorpPrice & Indicators
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EPS non-GAAP | $3.98 | Full year 2025 | — |
| Free cash flow non-GAAP | $773M | Full year 2025 | — |
| Operating EBITDA non-GAAP | $1,893M | Full year 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CE
this stock
Celanese Corp
|
$5.34B | +15.2% | -7.1% | — | 6.9% |
|
SHECF
Shin-Etsu Chemical Co., Ltd.
|
$82.75B | +30.9% | — | — | 0.2% |
|
DOW
Dow Inc.
|
$20.64B | +23.9% | -7.0% | — | 4.3% |
|
NPXYY
Nippon Sanso Holdings Corporation/ADR
|
$16.46B | +28.7% | — | — | 0.0% |
|
MEOH
Methanex Corp
|
$3.55B | +16.1% | — | — | 1.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CE | +6.0% | -4.6% | +6.7% | +5.8% | +15.2% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | +5.1% | -6.0% | -0.8% | +5.7% | +5.6% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.